Delivery Order SPE2DX15D8002-SPE2DX23F2WS3
Award Date
4/12/23
Potential Completion Date
5/3/23
Potential Value
$1.8K
Federal Agency
Medical Supply Chain
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Minot, ND, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,755.68 firm fixed-price contract is for the delivery of PROQUAD VIALS, a type of pharmaceutical product, with a performance period ending on December 21, 2023. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the ECAT Generation V Program, which allows...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,755.73, is for the delivery of PROQUAD VIALS, a pharmaceutical product. The contract is a firm-fixed-price Delivery Order with a period of performance through May 2, 2023. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, with a ceiling value of $3,231.24, is for the delivery of PROQUAD VIALS, a type of medical supply. The contract has an ultimate completion date of September 1, 2022. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 as part of the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,611.72 firm fixed-price contract is for the delivery of PROQUAD vials, a pharmaceutical product, with a performance period through August 7, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the agency's ECAT Generation V Program, which enables the company to provide a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $3,611.72 firm fixed-price delivery order is for the provision of PROQUAD VIALS, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract is associated with Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of PROQUAD VIALS, a pharmaceutical product. The contract has a ceiling value of $1,805.85 and an ultimate completion date of April 15, 2024. There is no set-aside designation for this award. As a prime contractor to the DLA, Dakota Drug, Inc. has over two decades of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a ceiling value of $1,805.85 and a completion date of May 30, 2024. The contract is a firm fixed-price delivery order and is not designated as a set-aside. As a prime contractor to the DLA, Dakota...
This federal contract award, with ID SPE2DB24D8001|SPE2DB25FKZHK, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of PROQUAD VIALS, which are likely pharmaceutical products or medical supplies. It is a firm fixed-price delivery order contract with a ceiling value of $1,836.34 and a period of performance extending to March 26, 2025. Dakota Drug, Inc. holds a significant...
This is a firm fixed-price delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a ceiling value of $1,805.85 and a period of performance through July 3, 2024. The contract was awarded on June 11, 2024 and does not have a set-aside designation. Dakota Drug, Inc. is a for-profit subchapter S corporation that...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,231.24 firm fixed-price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC), valued at $999,999,999.00, with the DLA as part of the ECAT Generation V...